Victory Capital Management
COGT icon

Victory Capital Management’s Cogent Biosciences COGT Stock Holding History

Victory Capital Management’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.03M Buy
129,925
+20,506
+19% +$717K ﹤0.01% 1365
2026
Q1 		$4.21M Buy
109,419
+57,833
+112% +$2.14M ﹤0.01% 1381
2025
Q4 		$1.83M Buy
51,586
+38,632
+298% +$1.09M ﹤0.01% 1606
2025
Q3 		$186K Buy
12,954
+1,742
+16% +$20.6K ﹤0.01% 2233
2025
Q2 		$80.5K Sell
11,212
-289
-3% -$1.6K ﹤0.01% 2348
2025
Q1 		$68.9K Buy
11,501
+501
+5% +$3.93K ﹤0.01% 2343
2024
Q4 		$85.8K Buy
11,000
+508
+5% +$5.06K ﹤0.01% 2349
2024
Q3 		$113K Buy
+10,492
New +$102K ﹤0.01% 2312
2024
Q2 		– Sell
-11,470
Closed -$77.1K – 2491
2024
Q1 		$77.1K Buy
+11,470
New +$70.9K ﹤0.01% 2331
2020
Q2 		– Sell
-633
Closed -$1K – 2675
2020
Q1 		$1K Buy
+633
New +$1.76K ﹤0.01% 3601
2019
Q4 		– Sell
-583
Closed -$3K – 2773
2019
Q3 		$3K Buy
+583
New +$4.74K ﹤0.01% 3550
2018
Q2 		– Sell
-62,500
Closed -$2.78M – 1831
2018
Q1 		$2.78M Buy
+62,500
New +$2.78M 0.01% 976

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Victory Capital Management's COGT Position: Q2 2026 in Review

Victory Capital Management increased its Cogent Biosciences (COGT) stake by 19% in Q2 2026, buying an estimated $717K and bringing the position to 129,925 shares worth $5.03M. The position accounts for ﹤0.01% of the portfolio, ranked #1365.

Victory Capital Management first reported a position in COGT in Q1 2018 and has held it in 12 quarters since. 324 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • Victory Capital Management held 129,925 shares of Cogent Biosciences worth $5.03M as of Q2 2026.
  • Victory Capital Management bought 20,506 Cogent Biosciences shares in Q2 2026, an estimated $717K.
  • Cogent Biosciences made up ﹤0.01% of Victory Capital Management's portfolio in Q2 2026, its #1365 holding.
  • Victory Capital Management first reported a position in Cogent Biosciences in Q1 2018 and has held it in 12 quarters since.
  • 324 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.